Suppr超能文献

开发和验证具有成本效益的 SYBR Green 实时 RT-qPCR,并在印度尼西亚的样本混合策略中评估其检测 SARS-CoV-2 感染的效果。

Development and validation of cost-effective SYBR Green-based RT-qPCR and its evaluation in a sample pooling strategy for detecting SARS-CoV-2 infection in the Indonesian setting.

机构信息

Microbiology and Biotechnology Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, West Java, Indonesia.

Helix Laboratory & Clinic, Depok, West Java, Indonesia.

出版信息

Sci Rep. 2024 Jan 20;14(1):1817. doi: 10.1038/s41598-024-52250-w.

Abstract

A low-cost SYBR Green-based RT-qPCR method to detect SARS-CoV-2 were developed and validated. Primers targeting a conserved and vital region of the N genes of SARS-CoV-2 were designed. In-silico study was performed to analyse the compatibility of the selected primer pair with Indonesian SARS-CoV-2 genome sequences available from the GISAID database. We determined the linearity of our new assay using serial dilution of SARS-CoV-2 RNA from clinical samples with known virus concentration. The assay was then evaluated using clinically relevant samples in comparison to a commercial TaqMan-based test kit. Finally, we applied the assay in sample pooling strategies for SARS-CoV-2 detection. The SYBR Green-based RT-qPCR method was successfully developed with sufficient sensitivity. There is a very low prevalence of genome variation in the selected N primer binding regions, indicating their high conservation. The validation of the assay using clinical samples demonstrated similar performance to the TaqMan method suggesting the SYBR methods is reliable. The pooling strategy by combining 5 RNA samples for SARS-CoV-2 detection using the SYBR RT-qPCR methods is feasible and provides a high diagnostic yield. However, when dealing with samples having a very low viral load, it may increase the risk of missing positive cases.

摘要

我们开发并验证了一种基于 SYBR Green 的低成本 RT-qPCR 方法来检测 SARS-CoV-2。我们设计了针对 SARS-CoV-2 N 基因保守且重要区域的引物。通过计算机模拟研究,分析了所选引物对与 GISAID 数据库中可用的印度尼西亚 SARS-CoV-2 基因组序列的兼容性。我们使用具有已知病毒浓度的临床样本中的 SARS-CoV-2 RNA 进行连续稀释,确定了我们新测定法的线性。然后,我们将该测定法与商业 TaqMan 检测试剂盒一起用于临床相关样本进行评估。最后,我们将该测定法应用于 SARS-CoV-2 的样本混合检测策略。该基于 SYBR Green 的 RT-qPCR 方法成功开发,具有足够的灵敏度。在选定的 N 引物结合区域中,基因组变异的发生率非常低,表明其高度保守。使用临床样本对该测定法进行验证,结果表明与 TaqMan 方法的性能相似,表明 SYBR 方法是可靠的。使用 SYBR RT-qPCR 方法对 5 个 RNA 样本进行 SARS-CoV-2 检测的混合策略是可行的,并且提供了较高的诊断率。然而,在处理病毒载量非常低的样本时,可能会增加漏检阳性病例的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fab/10799953/2a914fdfd6dc/41598_2024_52250_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验